Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05926245 · ClinicalTrials.gov registry record · Phase 1
Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection
A Phase 1 study, sponsored by Western University of Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT05926245 is a Phase 1 study that has completed, run by Western University of Health Sciences. The registered enrollment target is 30 participants.
The verdict
NCT05926245, a Phase 1 study, has completed, sponsored by Western University of Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The proposed clinical trial will confirm the therapeutic absorption of glutathione following topical Glutaryl application in increasing blood GSH levels without an invasive procedure. GOAL: Confirm therapeutic level of glutathione following topical transdermal application. HYPOTHESIS: The hypothesis of the proposed study is that the glutathione administration will increase RBC levels of glutathione above 80%. AIM: Determine a non-invasive way to increase glutathione levels in the plasma and blood cells. This aim will be accomplished as follows: STEP 1: We will recruit eligible healthy participants in the two study groups who are not currently taking any glutathione or N-acetyl cysteine (NAC) supplementation. STEP 2: Determine baseline levels of GSH, free radicals and cytokines through analysis of venipuncture blood draws. STEP 3: Study subjects will be asked to spray themselves with either placebo or Glutaryl four times twice a day for three days on the ventral part of the abdomen. Measure the levels of GSH, free radicals and cytokines after 1 hour, 4 hour and 72 hours.
Interventions
- DIETARY_SUPPLEMENT Glutaryl Solution
- DIETARY_SUPPLEMENT Placebo Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2022-12-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05926245
The ClinicalTrials.gov registry entry for NCT05926245 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Western University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glutaryl Solution is the first listed.
NCT05926245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05926245 about?
NCT05926245 is a clinical study titled "Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection". The proposed clinical trial will confirm the therapeutic absorption of glutathione following topical Glutaryl application in increasing blood GSH levels without an invasive procedure. GOAL: Confirm therapeutic level of glutathione following topical transdermal application. HYPOTHESIS: The hypothes...
What is the current status of trial NCT05926245?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2022-07-11. Estimated completion is 2022-12-14.
What interventions are being tested in trial NCT05926245?
The interventions under investigation include: Glutaryl Solution (DIETARY_SUPPLEMENT), Placebo Solution (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05926245?
This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.